Company Performance Metrics
In Transcription operates within the biotechnology industry, focusing on the advancement of life sciences through transcription research and development. With a team of 42 employees, the company engages in the exploration and understanding of RNA polymerase II-transcribed snRNA genes, regulatory lexicons encoded in transcription factor footprints,
and the role of transcription in cancer research. In Transcription collaborates with partner organizations such as VisionPlus Capital, Cephalo Ventures, and Initium Fund to foster innovation in the field. The company's research contributes to the broader scientific community's understanding of transcription regulation, transcription-coupled repair, and the association of mediator and RNA polymerase II clusters in transcription-dependent condensates.
